Haemostatic efficacy and safety of bolus and continuous infusion of recombinant factor VIIa are comparable in haemophilia patients with inhibitors undergoing major surgery. Results from an open-label, randomized, multicenter trial

Rajiv K. Pruthi, Prasad Mathew, Leonard A. Valentino, Michael J. Sumner, Stephanie Seremetis, W. Keith Hoots, M. Elaine Eyster, David Green, Anne Hurlet, Barbara Konkle, Cindy Leissinger, Jamie E. Siegel

Research output: Contribution to journalArticlepeer-review

61 Scopus citations

Fingerprint

Dive into the research topics of 'Haemostatic efficacy and safety of bolus and continuous infusion of recombinant factor VIIa are comparable in haemophilia patients with inhibitors undergoing major surgery. Results from an open-label, randomized, multicenter trial'. Together they form a unique fingerprint.

Medicine & Life Sciences